Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 518135, 6 pages
http://dx.doi.org/10.1155/2014/518135
Review Article

Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy

Transplant Immunology Unit, Division of Immunology and Allergy and Division of Laboratory Medicine, University Hospital of Geneva, 4 rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland

Received 9 April 2014; Revised 6 June 2014; Accepted 18 June 2014; Published 9 July 2014

Academic Editor: Jean-Marie Tiercy

Copyright © 2014 Casimir de Rham and Jean Villard. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind, and K. H. S. Campbell, “Viable offspring derived from fetal and adult mammalian cells,” Nature, vol. 385, no. 6619, pp. 810–813, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Wakayama, V. Tabar, I. Rodriguez, A. C. F. Perry, L. Studer, and P. Mombaerts, “Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer,” Science, vol. 292, no. 5517, pp. 740–743, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Bleakley and S. R. Riddell, “Molecules and mechanisms of the graft-versus-leukaemia effect,” Nature Reviews Cancer, vol. 4, no. 5, pp. 371–380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Spradling, D. Drummond-Barbosa, and T. Kai, “Stem cells find their niche,” Nature, vol. 414, no. 6859, pp. 98–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Gimble, A. J. Katz, and B. A. Bunnell, “Adipose-derived stem cells for regenerative medicine,” Circulation Research, vol. 100, no. 9, pp. 1249–1260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Volponi, Y. Pang, and P. T. Sharpe, “Stem cell-based biological tooth repair and regeneration,” Trends in Cell Biology, vol. 20, no. 12, pp. 715–722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Visvader and G. H. Smith, “Murine mammary epithelial stem cells: discovery, function, and current status,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 2, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. MacKay-Sim, “Stem cells and their niche in the adult olfactory mucosa,” Archives Italiennes de Biologie, vol. 148, no. 2, pp. 47–58, 2010. View at Google Scholar · View at Scopus
  11. R. J. Jakel, B. L. Schneider, and C. N. Svendsen, “Using human neural stem cells to model neurological disease,” Nature Reviews Genetics, vol. 5, no. 2, pp. 136–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Kuroda, M. Kitada, S. Wakao et al., “Unique multipotent cells in adult human mesenchymal cell populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 19, pp. 8639–8643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Wakao, H. Akashi, Y. Kushida, and M. Dezawa, “Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues,” Pathology International, vol. 64, pp. 1–9, 2014. View at Google Scholar
  14. Y. H. Loh, S. Agarwal, I. H. Park et al., “Generation of induced pluripotent stem cells from human blood,” Blood, vol. 113, no. 22, pp. 5476–5479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Aoi, K. Yae, M. Nakagawa et al., “Generation of pluripotent stem cells from adult mouse liver and stomach cells,” Science, vol. 321, pp. 699–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. B. Kim, H. Zaehres, G. Wu et al., “Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors,” Nature, vol. 454, no. 7204, pp. 646–650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Hussein, N. N. Batada, S. Vuoristo et al., “Copy number variation and selection during reprogramming to pluripotency,” Nature, vol. 471, no. 7336, pp. 58–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gore, Z. Li, H. Fung et al., “Somatic coding mutations in human induced pluripotent stem cells,” Nature, vol. 471, no. 7336, pp. 63–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Lister, M. Pelizzola, Y. S. Kida et al., “Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells,” Nature, vol. 471, no. 7336, pp. 68–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen, “Virus-free induction of pluripotency and subsequent excision of reprogramming factors,” Nature, vol. 458, no. 7239, pp. 771–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Pasha, H. K. Haider, and M. Ashraf, “Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells,” PLoS ONE, vol. 6, no. 8, Article ID e23667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Wang, Y. Miyagoe-Suzuki, E. Yada et al., “Reprogramming efficiency and quality of induced pluripotent stem cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages,” PLoS Currents, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Nakajima, K. Tokunaga, and N. Nakatsuji, “Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy,” Stem Cells, vol. 25, no. 4, pp. 983–985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Lin, Y. Xie, Q. OuYang et al., “HLA-matching potential of an established human embryonic stem cell bank in China,” Cell Stem Cell, vol. 5, no. 5, pp. 461–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. Taylor, S. Peacock, A. N. Chaudhry, J. A. Bradley, and E. M. Bolton, “Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient hla types,” Cell Stem Cell, vol. 11, no. 2, pp. 147–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Li, M. L. Baroja, A. Majumdar et al., “Human embryonic stem cells possess immune-privileged properties,” Stem Cells, vol. 22, no. 4, pp. 448–456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. P. Chidgey, D. Layton, A. Trounson, and R. L. Boyd, “Tolerance strategies for stem-cell-based therapies,” Nature, vol. 453, no. 7193, pp. 330–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Carpentier and T. D. Palmer, “Immune influence on adult neural stem cell regulation and function,” Neuron, vol. 64, no. 1, pp. 79–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. E. De Almeida, J. D. Ransohoff, A. Nahid, and J. C. Wu, “Immunogenicity of pluripotent stem cells and their derivatives,” Circulation Research, vol. 112, no. 3, pp. 549–561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. S. Scheiner, S. Talib, and E. G. Feigal, “The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies,” The Journal of Biological Chemistry, vol. 289, pp. 4571–4577, 2014. View at Google Scholar
  31. C. de Rham and J. Villard, “How to cross immunogenetic hurdles to human embryonic stem cell transplantation,” Seminars in Immunopathology, vol. 33, no. 6, pp. 525–534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Drukker, H. Katchman, G. Katz et al., “Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells,” Stem Cells, vol. 24, no. 2, pp. 221–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-G. Ljunggren and K. Karre, “In search of the “missing self”: MHC molecules and NK cell recognition,” Immunology Today, vol. 11, no. 7, pp. 237–244, 1990. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Opelz and B. Döhler, “Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades,” Transplantation, vol. 84, no. 2, pp. 137–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Kurtzberg, V. K. Prasad, S. L. Carter et al., “Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies,” Blood, vol. 112, no. 10, pp. 4318–4327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Opelz and B. Döhler, “Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation,” Transplantation, vol. 89, no. 5, pp. 567–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Opelz and B. Döhler, “Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-hodgkin lymphoma: a collaborative transplant study report,” Transplantation, vol. 90, no. 3, pp. 292–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. A. Copelan, “Hematopoietic stem-cell transplantation,” The New England Journal of Medicine, vol. 354, no. 17, pp. 1813–1826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Taylor, E. M. Bolton, S. Pocock, L. D. Sharples, R. A. Pedersen, and J. A. Bradley, “Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching,” The Lancet, vol. 366, pp. 2019–2025, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Fairchild, “The challenge of immunogenicity in the quest for induced pluripotency,” Nature Reviews Immunology, vol. 10, no. 12, pp. 868–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Tokunaga, J. Ohashi, M. Bannai, and T. Juji, “Genetic link between Asians and Native Americans: evidence from HLA genes and haplotypes,” Human Immunology, vol. 62, no. 9, pp. 1001–1008, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Kollman, M. Maiers, L. Gragert et al., “Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a National Registry with selective retyping of volunteers,” Human Immunology, vol. 68, no. 12, pp. 950–958, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Klitz, L. Gragert, M. Maiers et al., “Four-locus high-resolution HLA typing in a sample of Mexican Americans,” Tissue Antigens, vol. 74, no. 6, pp. 508–513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Lott and J. Savulescu, “Towards a global human embryonic stem cell bank,” American Journal of Bioethics, vol. 7, no. 8, pp. 37–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Zimmermann, O. Preynat-Seauve, J. Tiercy, K. Krause, and J. Villard, “Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations,” Stem Cells and Development, vol. 21, no. 13, pp. 2364–2373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. D. Kostyu, D. V. Dawson, S. Elias, and C. Ober, “Deficit of HLA homozygotes in a Caucasian isolate,” Human Immunology, vol. 37, no. 3, pp. 135–142, 1993. View at Google Scholar · View at Scopus
  47. A. M. Fraga, M. Sukoyan, P. Rajan et al., “Establishment of a Brazilian line of human embryonic stem cells in defined medium: implications for cell therapy in an ethnically diverse population,” Cell Transplantation, vol. 20, no. 3, pp. 431–440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Healy, C. Hunt, L. Young, and G. Stacey, “The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines,” Advanced Drug Delivery Reviews, vol. 57, no. 13, pp. 1981–1988, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. P. P. O'Rourke, M. Abelman, and K. G. Heffernan, “Centralized banks for human embryonic stem cells: a worthwhile challenge,” Cell Stem Cell, vol. 2, no. 4, pp. 307–312, 2008. View at Publisher · View at Google Scholar · View at Scopus